Indiabulls Property Management Trustee names Sri Murali as director

He has over 32 years of experience in the area of accounting, advisory and related financial management expertise.

Indiabulls Property Management Trustee announced the appointment of Sri Murali as non-executive independent director.

Mr Sri Murali, 56, will also be an Audit Committee Member.

He is managing partner of a public accounting firm with over 32 years of experience in the area of accounting, advisory and related financial management expertise. He is a member of Institute of Singapore Chartered Accountants and Association of Chartered Certified Accountants (United Kingdom).

Mr. Sri Murali has vast professional experience dealing with various clients in relation to accounting, audit, corporate secretarial work, compliance related matters, tax planning, advisory and other consulting assignments.

Mr. Sri Murali has earlier worked with other public accounting firms including Ernst & Young LLP and Touche Ross & Co.

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare